C

Cyfuse Biomedical KK
TSE:4892

Watchlist Manager
Cyfuse Biomedical KK
TSE:4892
Watchlist
Price: 579 JPY -5.7% Market Closed
Market Cap: ¥5.8B

Relative Value

The Relative Value of one Cyfuse Biomedical KK stock under the Base Case scenario is hidden JPY. Compared to the current market price of 579 JPY, Cyfuse Biomedical KK is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Cyfuse Biomedical KK Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Cyfuse Biomedical KK Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Cyfuse Biomedical KK
TSE:4892
5.6B JPY 24.1 -7.3 -3.8 -3.6
US
PerkinElmer Inc
LSE:0KHE
939.8B USD 329.1 3 896.5 1 116.6 2 150.2
US
Thermo Fisher Scientific Inc
NYSE:TMO
179.9B USD 4 26.8 18.7 25.1
US
Danaher Corp
NYSE:DHR
134.3B USD 5.5 37.2 18.9 27.5
KR
Samsung Biologics Co Ltd
KRX:207940
82.3T KRW 18.1 46.1 30.1 39.4
CH
Lonza Group AG
SIX:LONN
32.1B CHF 4.9 33.9 25.4 25.4
CN
WuXi AppTec Co Ltd
SSE:603259
251.1B CNY 5.7 16.7 16.7 16.7
US
Agilent Technologies Inc
NYSE:A
31.7B USD 4.5 24.5 18.1 21.4
US
Waters Corp
NYSE:WAT
29.6B USD 9.3 46 29.7 37.4
US
IQVIA Holdings Inc
NYSE:IQV
28.3B USD 1.7 20.9 11.7 17.6
US
Mettler-Toledo International Inc
NYSE:MTD
25.2B USD 6.3 29 21.6 24
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
JP
C
Cyfuse Biomedical KK
TSE:4892
Average EV/EBITDA: 130.8
Negative Multiple: -3.8
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 116.6
9%
124.1
US
Thermo Fisher Scientific Inc
NYSE:TMO
18.7
9%
2.1
US
Danaher Corp
NYSE:DHR
18.9
7%
2.7
KR
Samsung Biologics Co Ltd
KRX:207940
30.1
15%
2
CH
Lonza Group AG
SIX:LONN
25.4
31%
0.8
CN
WuXi AppTec Co Ltd
SSE:603259
16.7
31%
0.5
US
Agilent Technologies Inc
NYSE:A
18.1
12%
1.5
US
Waters Corp
NYSE:WAT
29.7
34%
0.9
US
IQVIA Holdings Inc
NYSE:IQV
11.7
10%
1.2
US
Mettler-Toledo International Inc
NYSE:MTD
21.6
7%
3.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
JP
C
Cyfuse Biomedical KK
TSE:4892
Average EV/EBIT: 238.5
Negative Multiple: -3.6
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
2 150.2
30%
71.7
US
Thermo Fisher Scientific Inc
NYSE:TMO
25.1
16%
1.6
US
Danaher Corp
NYSE:DHR
27.5
17%
1.6
KR
Samsung Biologics Co Ltd
KRX:207940
39.4
19%
2.1
CH
Lonza Group AG
SIX:LONN
25.4
17%
1.5
CN
WuXi AppTec Co Ltd
SSE:603259
16.7
24%
0.7
US
Agilent Technologies Inc
NYSE:A
21.4
19%
1.1
US
Waters Corp
NYSE:WAT
37.4
39%
1
US
IQVIA Holdings Inc
NYSE:IQV
17.6
18%
1
US
Mettler-Toledo International Inc
NYSE:MTD
24
8%
3
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett